Riverbridge Partners LLC Has $9.17 Million Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Riverbridge Partners LLC cut its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 4.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 372,478 shares of the company's stock after selling 18,296 shares during the quarter. Riverbridge Partners LLC owned 1.53% of OrthoPediatrics worth $9,174,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of KIDS. Rhumbline Advisers lifted its stake in OrthoPediatrics by 4.1% during the fourth quarter. Rhumbline Advisers now owns 26,411 shares of the company's stock valued at $612,000 after buying an additional 1,042 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of OrthoPediatrics by 3.8% in the fourth quarter. Bank of New York Mellon Corp now owns 57,710 shares of the company's stock worth $1,338,000 after purchasing an additional 2,099 shares in the last quarter. Mutual of America Capital Management LLC lifted its position in shares of OrthoPediatrics by 57.1% in the fourth quarter. Mutual of America Capital Management LLC now owns 169,021 shares of the company's stock worth $3,918,000 after purchasing an additional 61,412 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of OrthoPediatrics by 2.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,234 shares of the company's stock worth $3,158,000 after purchasing an additional 3,800 shares in the last quarter. Finally, HighTower Advisors LLC purchased a new stake in shares of OrthoPediatrics in the fourth quarter worth approximately $268,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Stock Up 1.5%

NASDAQ:KIDS traded up $0.30 during mid-day trading on Monday, reaching $20.59. The stock had a trading volume of 161,669 shares, compared to its average volume of 200,114. The business's 50 day moving average is $21.34 and its 200 day moving average is $23.11. OrthoPediatrics Corp. has a fifty-two week low of $19.52 and a fifty-two week high of $35.99. The stock has a market cap of $500.13 million, a P/E ratio of -11.77 and a beta of 1.08. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.19 and a quick ratio of 2.99.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). OrthoPediatrics had a negative return on equity of 7.03% and a negative net margin of 19.15%. The firm had revenue of $52.41 million during the quarter, compared to analyst estimates of $51.68 million. As a group, sell-side analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on KIDS. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price target on shares of OrthoPediatrics in a research report on Thursday, May 8th. Truist Financial reduced their price target on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Wall Street Zen lowered shares of OrthoPediatrics from a "hold" rating to a "sell" rating in a research report on Friday, June 6th. Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating for the company in a research report on Wednesday, March 5th. Finally, Lake Street Capital began coverage on shares of OrthoPediatrics in a research report on Monday, April 7th. They issued a "buy" rating and a $37.00 price target for the company. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $35.83.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.